Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ikram el Azzouzi"'
Autor:
Maarten P. van Wiechen, Ikram el Azzouzi, Wiebe G. Knol, Rik Adrichem, Thijmen W. Hokken, Joris F. Ooms, Marjo J. de Ronde-Tillmans, Joost Daemen, Peter P. de Jaegere, Alexander Hirsch, Ricardo P.J. Budde, Nicolas M. Van Mieghem
Publikováno v:
Cardiovascular Revascularization Medicine, 44, 67-70. Elsevier Inc.
Background: Multislice computed tomography (MSCT) may reveal hypo-attenuated leaflet thickening (HALT) and/or reduced leaflet motion (RELM) in approximately 15 % of patients after transcatheter aortic valve replacement (TAVR). These supposedly thromb
Autor:
Maarten P van Wiechen, Isabella Kardys, Nicolas M. Van Mieghem, Ikram El Azzouzi, Joris F. Ooms, Joost Daemen, Peter P de Jaegere, Thijmen W. Hokken, Ricardo P.J. Budde, Marjo de Ronde
Publikováno v:
International Journal of Cardiology, 333, 152-158. Elsevier Ireland Ltd
Background The need for new permanent pacemaker implantation (PPI) after Transcatheter Aortic Valve Implantation (TAVI) remains a critical issue. Membranous Septum (MS) length is associated with PPI after TAVI. The aim of this study was to identify d
Autor:
Ikram El Azzouzi, Ricardo P.J. Budde, Nicolas M. Van Mieghem, Maarten P van Wiechen, Thijmen W. Hokken, Quinten M. Wolff, Joris F. Ooms
Publikováno v:
Structural Heart: the journal of the Heart Team, 5(5), 532-534. Taylor & Francis Ltd
Transcatheter aortic valve replacement (TAVR) is an established treatment for severe aortic stenosis (AS); however, the transcatheter heart valve (THV) implantation depth (ID) is associated with co...
Autor:
Masahiko Asami, Stefan Stortecky, Joris F. Ooms, Ikram El Azzouzi, Joost Daemen, Thomas Pilgrim, Peter P de Jaegere, Nicolas M. Van Mieghem, Francesca Ziviello, Stephan Windecker, Maarten P van Wiechen, Herbert Kroon
Publikováno v:
Minerva Medica, 111(3), 203-212. Edizioni Minerva Medica
Background The optimal antithrombotic therapy after transcatheter aortic valve implantation (TAVI) is unsettled. Short and longer-term thromboembolic and bleeding risk post TAVI remain high. Non-vitamin K oral anticoagulant drugs (NOAC) may be attrac
Autor:
Ikram El Azzouzi, Ernest Spitzer, Jeroen J. Bax, Guillaume Jean, Philippe Pibarot, Lennart van Gils, E M Vollema, Nicolas M. Van Mieghem, Marie-Annick Clavel, Victoria Delgado
Publikováno v:
Journal of the American College of Cardiology. 75:2122
We recently demonstrated that moderate aortic stenosis (AS) in patient with systolic heart failure (HF) is associated with poor outcome. However, it is unknown how the prognosis of these patients compare to that of patients with systolic HF and no AS